Breaking News: Top Investment Opportunities Unveiled by Industry Leaders!

๐Ÿ“ˆ Bilservicebolaget Meko reports a operating profit of 284 million SEK for Q2 2024 (304).

The operating margin was 6.0% (6.8).

The result has been affected by comparison-disturbing items of -48 million SEK (+59).

Adjusted operating profit amounted to 357 million SEK (270), with an adjusted operating margin of 7.5% (6.2).

Net sales amounted to 4,680 million SEK (4,292). The organic growth was 5%.

๐Ÿ› ๏ธ Installation company Instalco reports an operating profit for Q2 2024 of 224 million SEK (244).

The turnover was 3,656 million SEK (3,832). The organic growth was -6.4%.

At the end of Q2, the order backlog amounted to 9,058 million SEK (9,185).

Ebita result amounted to 265 million SEK (296), corresponding to an ebita margin of 7.2% (7.7).

๐ŸŽฐ The Danish affiliate company Better Collective reports an adjusted ebitda result of 28.5 million euros for Q2 2024 (28.7). The adjusted ebitda margin was 29% (37).

Net sales amounted to 99.1 million euros (78.1). Sales growth was 27% (39) and organic growth was 5% (29).

As part of Better Collective’s acquisition of the British sports betting company Aceodds on May 16 this year, the company updated several financial goals for 2024. These goals are confirmed in the report and remain unchanged.

Revenues are expected to reach 395โ€“425 million euros in 2024, representing a growth of 21-30%. The ebitda target remains at 130-140 million euros, representing a growth of 17โ€“26%. Net debt should be less than three times ebitda.

๐Ÿงช Research company Egetis Therapeutics reports an operating result of -75.2 million SEK for Q2 2024 (-80.3).

The net profit was -71.9 million SEK (-79.5).

Analysis:
– Bilservicebolaget Meko and Installation company Instalco show positive financial performance with strong operating profits and margins.
– Better Collective’s growth remains steady with promising revenue projections for 2024.
– Egetis Therapeutics continues to face challenges with a negative operating result for Q2 2024. Investors should carefully consider the risks associated with this company.

Shares: